RobertLeongMD

PubMed

• 240 citations
  Oral Hypoxia–Inducible Factor Prolyl Hydroxylase Inhibitor Roxadustat (FG-4592) for the Treatment of Anemia in Patients with CKD
  Robert Provenzano, Anatole Besarab, Chao H. Sun, Susan A. Diamond, John H. Durham, Jose L. Cangiano, Joseph R. Aiello, James E. Novak, Tyson Lee, Robert Leong, Brian K...> ;Clinical Journal of the American Society of Nephrology. 2016 Jun 6
• 187 citations
  Roxadustat (FG-4592): Correction of Anemia in Incident Dialysis Patients
  Anatole Besarab, Elena Chernyavskaya, Igor Motylev, Evgeny Shutov, Lalathaksha Kumbar, Konstantin Gurevich, Daniel Tak Mao Chan, Robert Leong, Lona Poole, Ming Zhong, ...> ;Journal of the American Society of Nephrology. 2016 Apr 1

Journal Articles

• Roxadustat Treatment for Anemia in Patients Undergoing Long-Term Dialysis  
  Nan Chen, M.D., Chuanming Hao, M.D., Ph.D., Bi-Cheng Liu, M.D., Ph.D., Hongli Lin, M.D., Ph.D., Caili Wang, B.Sc., Changying Xing, M.D., Ph.D., Xinling Liang, M.D., Ph..., New England Journal of Medicine, 7/24/2019
• Roxadustat for Anemia in Patients with Kidney Disease Not Receiving Dialysis  
  Nan Chen, M.D., Chuanming Hao, M.D., Ph.D., Xiaomei Peng, B.Sc., Hongli Lin, M.D., Ph.D., Aiping Yin, Ph.D., Li Hao, M.Sc., Ye Tao, M.D., Xinling Liang, M.D., Ph.D., Z..., New England Journal of Medicine, 7/24/2019